{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:51:02Z","timestamp":1790351462684,"version":"4.1.0"},"publisher-location":"Singapore","reference-count":104,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811373411","type":"print"},{"value":"9789811373428","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-13-7342-8_2","type":"book-chapter","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T07:03:32Z","timestamp":1563865412000},"page":"41-57","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cellular and Molecular State of Myeloid Leukemia Stem Cells"],"prefix":"10.1007","author":[{"given":"Xueqin","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdie","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,24]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1073\/pnas.51.1.29","volume":"51","author":"JE Till","year":"1964","unstructured":"Till JE, McCulloch EA, Siminovitch L (1964) A stochastic model of stem cell proliferation, based on the growth of spleen Colony-forming cells. Proc Natl Acad Sci U S A 51:29\u201336","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2_CR2","first-page":"362","volume":"1","author":"AP Korn","year":"1973","unstructured":"Korn AP, Henkelman RM, Ottensmeyer FP, Till JE (1973) Investigations of a stochastic model of haemopoiesis. Exp Hematol 1(6):362\u2013375","journal-title":"Exp Hematol"},{"issue":"6","key":"2_CR3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","volume":"10","author":"JE Visvader","year":"2012","unstructured":"Visvader JE, Lindeman GJ (2012) Cancer stem cells: current status and evolving complexities. Cell Stem Cell 10(6):717\u2013728","journal-title":"Cell Stem Cell"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/199079a0","volume":"199","author":"WR Bruce","year":"1963","unstructured":"Bruce WR, Van Der Gaag H (1963) A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 199:79\u201380","journal-title":"Nature"},{"issue":"6859","key":"2_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105\u2013111","journal-title":"Nature"},{"issue":"7","key":"2_CR6","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3(7):730\u2013737","journal-title":"Nat Med"},{"issue":"7","key":"2_CR7","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100(7):3983\u20133988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"2_CR8","first-page":"5821","volume":"63","author":"SK Singh","year":"2003","unstructured":"Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J et\u00a0al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63(18):5821\u20135828","journal-title":"Cancer Res"},{"issue":"3","key":"2_CR9","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","volume":"67","author":"C Li","year":"2007","unstructured":"Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V et al (2007) Identification of pancreatic cancer stem cells. Cancer Res 67(3):1030\u20131037","journal-title":"Cancer Res"},{"issue":"7123","key":"2_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature05384","volume":"445","author":"L Ricci-Vitiani","year":"2007","unstructured":"Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C et al (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445(7123):111\u2013115","journal-title":"Nature"},{"issue":"6","key":"2_CR11","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2005.03.032","volume":"121","author":"CF Kim","year":"2005","unstructured":"Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S et al (2005) Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121(6):823\u2013835","journal-title":"Cell"},{"issue":"5991","key":"2_CR12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1126\/science.1189992","volume":"329","author":"AS Goldstein","year":"2010","unstructured":"Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON (2010) Identification of a cell of origin for human prostate cancer. Science 329(5991):568\u2013571","journal-title":"Science"},{"issue":"6","key":"2_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrc2147","volume":"7","author":"JV Melo","year":"2007","unstructured":"Melo JV, Barnes DJ (2007) Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 7(6):441\u2013453","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"2_CR14","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.tcb.2005.07.004","volume":"15","author":"JC Wang","year":"2005","unstructured":"Wang JC, Dick JE (2005) Cancer stem cells: lessons from leukemia. Trends Cell Biol 15(9):494\u2013501","journal-title":"Trends Cell Biol"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev.immunol.22.012703.104753","volume":"22","author":"S Wong","year":"2004","unstructured":"Wong S, Witte ON (2004) The BCR-ABL story: bench to bedside and back. Annu Rev Immunol 22:247\u2013306","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"2_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrc2368","volume":"8","author":"M Savona","year":"2008","unstructured":"Savona M, Talpaz M (2008) Getting to the stem of chronic myeloid leukaemia. Nat Rev Cancer 8(5):341\u2013350","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nrc1567","volume":"5","author":"R Ren","year":"2005","unstructured":"Ren R (2005) Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 5(3):172\u2013183","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"2_CR18","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H Dohner","year":"2015","unstructured":"Dohner H, Weisdorf DJ, Bloomfield CD (2015) Acute myeloid leukemia. N Engl J Med 373(12):1136\u20131152","journal-title":"N Engl J Med"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1349.001","volume":"1044","author":"JE Dick","year":"2005","unstructured":"Dick JE (2005) Acute myeloid leukemia stem cells. Ann N Y Acad Sci 1044:1\u20135","journal-title":"Ann N Y Acad Sci"},{"issue":"45","key":"2_CR20","doi-asserted-by":"publisher","first-page":"16870","DOI":"10.1073\/pnas.0606509103","volume":"103","author":"Y Hu","year":"2006","unstructured":"Hu Y, Swerdlow S, Duffy TM, Weinmann R, Lee FY, Li S (2006) Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice. Proc Natl Acad Sci U S A 103(45):16870\u201316875","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/blood.V99.1.319","volume":"99","author":"SM Graham","year":"2002","unstructured":"Graham SM, Jorgensen HG, Allan E, Pearson C, Alcorn MJ, Richmond L et al (2002) Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 99(1):319\u2013325","journal-title":"Blood"},{"issue":"9","key":"2_CR22","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1038\/bcj.2011.35","volume":"1","author":"D Wisniewski","year":"2011","unstructured":"Wisniewski D, Affer M, Willshire J, Clarkson B (2011) Further phenotypic characterization of the primitive lineage- CD34+CD38-CD90+CD45RA- hematopoietic stem cell\/progenitor cell sub-population isolated from cord blood, mobilized peripheral blood and patients with chronic myelogenous leukemia. Blood Cancer J 1(9):e36","journal-title":"Blood Cancer J"},{"issue":"25","key":"2_CR23","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","volume":"123","author":"H Herrmann","year":"2014","unstructured":"Herrmann H, Sadovnik I, Cerny-Reiterer S, Rulicke T, Stefanzl G, Willmann M et al (2014) Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia. Blood 123(25):3951\u20133962","journal-title":"Blood"},{"issue":"12","key":"2_CR24","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1073\/pnas.1100551108","volume":"108","author":"M Jan","year":"2011","unstructured":"Jan M, Chao MP, Cha AC, Alizadeh AA, Gentles AJ, Weissman IL et al (2011) Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker. Proc Natl Acad Sci U S A 108(12):5009\u20135014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.stem.2015.07.011","volume":"17","author":"Y Kikushige","year":"2015","unstructured":"Kikushige Y, Miyamoto T, Yuda J, Jabbarzadeh-Tabrizi S, Shima T, Takayanagi S et al (2015) A TIM-3\/Gal-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemic progression. Cell Stem Cell 17(3):341\u2013352","journal-title":"Cell Stem Cell"},{"issue":"6","key":"2_CR26","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.stem.2010.11.014","volume":"7","author":"Y Kikushige","year":"2010","unstructured":"Kikushige Y, Shima T, Takayanagi S, Urata S, Miyamoto T, Iwasaki H et al (2010) TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells. Cell Stem Cell 7(6):708\u2013717","journal-title":"Cell Stem Cell"},{"issue":"2","key":"2_CR27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","volume":"138","author":"R Majeti","year":"2009","unstructured":"Majeti R, Chao MP, Alizadeh AA, Pang WW, Jaiswal S, Gibbs KD Jr et al (2009) CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 138(2):286\u2013299","journal-title":"Cell"},{"issue":"13","key":"2_CR28","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1182\/blood-2005-03-1072","volume":"106","author":"DC Taussig","year":"2005","unstructured":"Taussig DC, Pearce DJ, Simpson C, Rohatiner AZ, Lister TA, Kelly G et al (2005) Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia. Blood 106(13):4086\u20134092","journal-title":"Blood"},{"issue":"17","key":"2_CR29","doi-asserted-by":"publisher","first-page":"17ra9","DOI":"10.1126\/scitranslmed.3000349","volume":"2","author":"Y Saito","year":"2010","unstructured":"Saito Y, Kitamura H, Hijikata A, Tomizawa-Murasawa M, Tanaka S, Takagi S et al (2010) Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. Sci Transl Med 2(17):17ra9","journal-title":"Sci Transl Med"},{"issue":"12","key":"2_CR30","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1182\/blood-2016-10-696054","volume":"129","author":"D Thomas","year":"2017","unstructured":"Thomas D, Majeti R (2017) Biology and relevance of human acute myeloid leukemia stem cells. Blood 129(12):1577\u20131585","journal-title":"Blood"},{"issue":"1","key":"2_CR31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ccr.2010.12.012","volume":"19","author":"N Goardon","year":"2011","unstructured":"Goardon N, Marchi E, Atzberger A, Quek L, Schuh A, Soneji S et al (2011) Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell 19(1):138\u2013152","journal-title":"Cancer Cell"},{"issue":"2","key":"2_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.stem.2018.01.011","volume":"22","author":"RL Bowman","year":"2018","unstructured":"Bowman RL, Busque L, Levine RL (2018) Clonal hematopoiesis and evolution to hematopoietic malignancies. Cell Stem Cell 22(2):157\u2013170","journal-title":"Cell Stem Cell"},{"issue":"7","key":"2_CR33","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/nm.4125","volume":"22","author":"S Li","year":"2016","unstructured":"Li S, Garrett-Bakelman FE, Chung SS, Sanders MA, Hricik T, Rapaport F et al (2016) Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia. Nat Med 22(7):792\u2013799","journal-title":"Nat Med"},{"issue":"5","key":"2_CR34","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.cell.2017.04.018","volume":"169","author":"N Cabezas-Wallscheid","year":"2017","unstructured":"Cabezas-Wallscheid N, Buettner F, Sommerkamp P, Klimmeck D, Ladel L, Thalheimer FB et al (2017) Vitamin A-retinoic acid signaling regulates hematopoietic stem cell dormancy. Cell 169(5):807\u201323 e19","journal-title":"Cell"},{"issue":"7644","key":"2_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nature21388","volume":"543","author":"TT Ho","year":"2017","unstructured":"Ho TT, Warr MR, Adelman ER, Lansinger OM, Flach J, Verovskaya EV et al (2017) Autophagy maintains the metabolism and function of young and old stem cells. Nature 543(7644):205\u2013210","journal-title":"Nature"},{"issue":"1","key":"2_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.stem.2012.10.011","volume":"12","author":"K Takubo","year":"2013","unstructured":"Takubo K, Nagamatsu G, Kobayashi CI, Nakamura-Ishizu A, Kobayashi H, Ikeda E et al (2013) Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell 12(1):49\u201361","journal-title":"Cell Stem Cell"},{"issue":"7498","key":"2_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature13035","volume":"509","author":"RA Signer","year":"2014","unstructured":"Signer RA, Magee JA, Salic A, Morrison SJ (2014) Haematopoietic stem cells require a highly regulated protein synthesis rate. Nature 509(7498):49\u201354","journal-title":"Nature"},{"issue":"5","key":"2_CR38","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674","journal-title":"Cell"},{"issue":"3","key":"2_CR39","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.stem.2010.07.011","volume":"7","author":"T Simsek","year":"2010","unstructured":"Simsek T, Kocabas F, Zheng J, Deberardinis RJ, Mahmoud AI, Olson EN et al (2010) The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 7(3):380\u2013390","journal-title":"Cell Stem Cell"},{"issue":"5","key":"2_CR40","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","volume":"34","author":"CL Jones","year":"2018","unstructured":"Jones CL, Stevens BM, D\u2019Alessandro A, Reisz JA, Culp-Hill R, Nemkov T et al (2018) Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell 34(5):724\u201340 e4","journal-title":"Cancer Cell"},{"issue":"3","key":"2_CR41","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M et al (2013) BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell 12(3):329\u2013341","journal-title":"Cell Stem Cell"},{"issue":"10","key":"2_CR42","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/nm.4399","volume":"23","author":"EM Kuntz","year":"2017","unstructured":"Kuntz EM, Baquero P, Michie AM, Dunn K, Tardito S, Holyoake TL et al (2017) Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells. Nat Med 23(10):1234\u20131240","journal-title":"Nat Med"},{"issue":"1","key":"2_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cell.2013.03.004","volume":"153","author":"WG Kaelin Jr","year":"2013","unstructured":"Kaelin WG Jr, McKnight SL (2013) Influence of metabolism on epigenetics and disease. Cell 153(1):56\u201369","journal-title":"Cell"},{"issue":"7680","key":"2_CR44","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature24294","volume":"551","author":"S Raffel","year":"2017","unstructured":"Raffel S, Falcone M, Kneisel N, Hansson J, Wang W, Lutz C et al (2017) BCAT1 restricts alphaKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation. Nature 551(7680):384\u2013388","journal-title":"Nature"},{"issue":"10","key":"2_CR45","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1128\/MCB.05672-11","volume":"32","author":"H Zhang","year":"2012","unstructured":"Zhang H, Li H, Ho N, Li D, Li S (2012) Scd1 plays a tumor-suppressive role in survival of leukemia stem cells and the development of chronic myeloid leukemia. Mol Cell Biol 32(10):1776\u20131787","journal-title":"Mol Cell Biol"},{"issue":"7655","key":"2_CR46","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nature22314","volume":"545","author":"A Hattori","year":"2017","unstructured":"Hattori A, Tsunoda M, Konuma T, Kobayashi M, Nagy T, Glushka J et\u00a0al (2017) Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature 545(7655):500\u2013504","journal-title":"Nature"},{"issue":"1","key":"2_CR47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2013.03.002","volume":"153","author":"LA Garraway","year":"2013","unstructured":"Garraway LA, Lander ES (2013) Lessons from the cancer genome. Cell 153(1):17\u201337","journal-title":"Cell"},{"issue":"7","key":"2_CR48","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc2876","volume":"10","author":"P Chi","year":"2010","unstructured":"Chi P, Allis CD, Wang GG (2010) Covalent histone modifications\u00a0\u2013 miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 10(7):457\u2013469","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"2_CR49","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1158\/2159-8290.CD-15-1439","volume":"6","author":"H Xie","year":"2016","unstructured":"Xie H, Peng C, Huang J, Li BE, Kim W, Smith EC et al (2016) Chronic myelogenous leukemia- initiating cells require Polycomb group protein EZH2. Cancer Discov 6(11):1237\u20131247","journal-title":"Cancer Discov"},{"issue":"11","key":"2_CR50","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1158\/2159-8290.CD-16-0263","volume":"6","author":"MT Scott","year":"2016","unstructured":"Scott MT, Korfi K, Saffrey P, Hopcroft LE, Kinstrie R, Pellicano F et al (2016) Epigenetic reprogramming sensitizes CML stem cells to combined EZH2 and tyrosine kinase inhibition. Cancer Discov 6(11):1248\u20131257","journal-title":"Cancer Discov"},{"issue":"1","key":"2_CR51","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1158\/1078-0432.CCR-17-1533","volume":"24","author":"J Zhou","year":"2018","unstructured":"Zhou J, Nie D, Li J, Du X, Lu Y, Li Y et al (2018) PTEN is fundamental for elimination of leukemia stem cells mediated by GSK126 targeting EZH2 in chronic myelogenous leukemia. Clin Cancer Res 24(1):145\u2013157","journal-title":"Clin Cancer Res"},{"issue":"12","key":"2_CR52","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","volume":"24","author":"DA Pollyea","year":"2018","unstructured":"Pollyea DA, Stevens BM, Jones CL, Winters A, Pei S, Minhajuddin M et al (2018) Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia. Nat Med 24(12):1859\u20131866","journal-title":"Nat Med"},{"issue":"6","key":"2_CR53","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","volume":"12","author":"C Zhao","year":"2007","unstructured":"Zhao C, Blum J, Chen A, Kwon HY, Jung SH, Cook JM et al (2007) Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 12(6):528\u2013541","journal-title":"Cancer Cell"},{"issue":"7239","key":"2_CR54","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nature07737","volume":"458","author":"C Zhao","year":"2009","unstructured":"Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J et\u00a0al (2009) Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458(7239):776\u2013779","journal-title":"Nature"},{"issue":"7281","key":"2_CR55","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nature08734","volume":"463","author":"K Naka","year":"2010","unstructured":"Naka K, Hoshii T, Muraguchi T, Tadokoro Y, Ooshio T, Kondo Y et al (2010) TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature 463(7281):676\u2013680","journal-title":"Nature"},{"issue":"12","key":"2_CR56","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","volume":"129","author":"TL Holyoake","year":"2017","unstructured":"Holyoake TL, Vetrie D (2017) The chronic myeloid leukemia stem cell: stemming the tide of persistence. Blood 129(12):1595\u20131606","journal-title":"Blood"},{"issue":"7","key":"2_CR57","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1182\/blood-2004-04-1335","volume":"104","author":"J Cortes","year":"2004","unstructured":"Cortes J, O\u2019Brien S, Kantarjian H (2004) Discontinuation of imatinib therapy after achieving a molecular response. Blood 104(7):2204\u20132205","journal-title":"Blood"},{"key":"2_CR58","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","volume":"119","author":"AHG Hamilton","year":"2012","unstructured":"Hamilton AHG, Schemionek M, Zhang B, Myssina S, Allan EK, Nicolini FE, M\u00fcller-Tidow C, Bhatia R, Brunton VG, Koschmieder S, Holyoake TL (2012) Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival. Blood 119:1501","journal-title":"Blood"},{"issue":"1","key":"2_CR59","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1172\/JCI35721","volume":"121","author":"AS Corbin","year":"2011","unstructured":"Corbin AS, Agarwal A, Loriaux M, Cortes J, Deininger MW, Druker BJ (2011) Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J Clin Invest 121(1):396\u2013409","journal-title":"J Clin Invest"},{"issue":"7","key":"2_CR60","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/ng.389","volume":"41","author":"Y Chen","year":"2009","unstructured":"Chen Y, Hu Y, Zhang H, Peng C, Li S (2009) Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat Genet 41(7):783\u2013792","journal-title":"Nat Genet"},{"issue":"8","key":"2_CR61","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ng.2350","volume":"44","author":"H Zhang","year":"2012","unstructured":"Zhang H, Peng C, Hu Y, Li H, Sheng Z, Chen Y et al (2012) The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells. Nat Genet 44(8):861\u2013871","journal-title":"Nat Genet"},{"issue":"2","key":"2_CR62","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.stem.2007.05.015","volume":"1","author":"B Dykstra","year":"2007","unstructured":"Dykstra B, Kent D, Bowie M, McCaffrey L, Hamilton M, Lyons K et al (2007) Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell 1(2):218\u2013229","journal-title":"Cell Stem Cell"},{"issue":"3","key":"2_CR63","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.stem.2012.02.007","volume":"10","author":"C Benz","year":"2012","unstructured":"Benz C, Copley MR, Kent DG, Wohrer S, Cortes A, Aghaeepour N et al (2012) Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs. Cell Stem Cell 10(3):273\u2013283","journal-title":"Cell Stem Cell"},{"issue":"7604","key":"2_CR64","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nature17997","volume":"533","author":"F Zhou","year":"2016","unstructured":"Zhou F, Li X, Wang W, Zhu P, Zhou J, He W et al (2016) Tracing haematopoietic stem cell formation at single-cell resolution. Nature 533(7604):487\u2013492","journal-title":"Nature"},{"issue":"11","key":"2_CR65","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","volume":"11","author":"FX Mahon","year":"2010","unstructured":"Mahon FX, Rea D, Guilhot J, Guilhot F, Huguet F, Nicolini F et al (2010) Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial. Lancet Oncol 11(11):1029\u20131035","journal-title":"Lancet Oncol"},{"issue":"13","key":"2_CR66","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1182\/blood-2011-02-335497","volume":"118","author":"JC Chomel","year":"2011","unstructured":"Chomel JC, Bonnet ML, Sorel N, Bertrand A, Meunier MC, Fichelson S et al (2011) Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease. Blood 118(13):3657\u20133660","journal-title":"Blood"},{"issue":"10","key":"2_CR67","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1038\/leu.2010.185","volume":"24","author":"DM Ross","year":"2010","unstructured":"Ross DM, Branford S, Seymour JF, Schwarer AP, Arthur C, Bartley PA et al (2010) Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR. Leukemia 24(10):1719\u20131724","journal-title":"Leukemia"},{"issue":"6","key":"2_CR68","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","volume":"119","author":"A Hamilton","year":"2012","unstructured":"Hamilton A, Helgason GV, Schemionek M, Zhang B, Myssina S, Allan EK et al (2012) Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival. Blood 119(6):1501\u20131510","journal-title":"Blood"},{"issue":"3","key":"2_CR69","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1172\/JCI79196","volume":"126","author":"B Zhang","year":"2016","unstructured":"Zhang B, Li L, Ho Y, Li M, Marcucci G, Tong W et al (2016) Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells. J Clin Invest 126(3):975\u2013991","journal-title":"J Clin Invest"},{"issue":"6","key":"2_CR70","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nm.4336","volume":"23","author":"A Giustacchini","year":"2017","unstructured":"Giustacchini A, Thongjuea S, Barkas N, Woll PS, Povinelli BJ, Booth CAG et al (2017) Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia. Nat Med 23(6):692\u2013702","journal-title":"Nat Med"},{"key":"2_CR71","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.gde.2016.03.011","volume":"36","author":"S Li","year":"2016","unstructured":"Li S, Mason CE, Melnick A (2016) Genetic and epigenetic heterogeneity in acute myeloid leukemia. Curr Opin Genet Dev 36:100\u2013106","journal-title":"Curr Opin Genet Dev"},{"issue":"281","key":"2_CR72","doi-asserted-by":"publisher","first-page":"281re2","DOI":"10.1126\/scitranslmed.aaa0763","volume":"7","author":"AL Paguirigan","year":"2015","unstructured":"Paguirigan AL, Smith J, Meshinchi S, Carroll M, Maley C, Radich JP (2015) Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia. Sci Transl Med 7(281):281re2","journal-title":"Sci Transl Med"},{"issue":"2","key":"2_CR73","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","volume":"150","author":"JS Welch","year":"2012","unstructured":"Welch JS, Ley TJ, Link DC, Miller CA, Larson DE, Koboldt DC et al (2012) The origin and evolution of mutations in acute myeloid leukemia. Cell 150(2):264\u2013278","journal-title":"Cell"},{"issue":"7382","key":"2_CR74","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature10738","volume":"481","author":"L Ding","year":"2012","unstructured":"Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS et al (2012) Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481(7382):506\u2013510","journal-title":"Nature"},{"issue":"7488","key":"2_CR75","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature13038","volume":"506","author":"LI Shlush","year":"2014","unstructured":"Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V et al (2014) Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature 506(7488):328\u2013333","journal-title":"Nature"},{"issue":"12","key":"2_CR76","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/nm.3733","volume":"20","author":"M Xie","year":"2014","unstructured":"Xie M, Lu C, Wang J, McLellan MD, Johnson KJ, Wendl MC et al (2014) Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med 20(12):1472\u20131478","journal-title":"Nat Med"},{"issue":"13","key":"2_CR77","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1182\/blood-2009-06-229757","volume":"115","author":"A Gerrits","year":"2010","unstructured":"Gerrits A, Dykstra B, Kalmykowa OJ, Klauke K, Verovskaya E, Broekhuis MJ et al (2010) Cellular barcoding tool for clonal analysis in the hematopoietic system. Blood 115(13):2610\u20132618","journal-title":"Blood"},{"issue":"7522","key":"2_CR78","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nature13824","volume":"514","author":"J Sun","year":"2014","unstructured":"Sun J, Ramos A, Chapman B, Johnnidis JB, Le L, Ho YJ et al (2014) Clonal dynamics of native haematopoiesis. Nature 514(7522):322\u2013327","journal-title":"Nature"},{"issue":"5","key":"2_CR79","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.stem.2014.10.015","volume":"15","author":"M Etzrodt","year":"2014","unstructured":"Etzrodt M, Endele M, Schroeder T (2014) Quantitative single-cell approaches to stem cell research. Cell Stem Cell 15(5):546\u2013558","journal-title":"Cell Stem Cell"},{"issue":"6","key":"2_CR80","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ni.3412","volume":"17","author":"R Drissen","year":"2016","unstructured":"Drissen R, Buza-Vidas N, Woll P, Thongjuea S, Gambardella A, Giustacchini A et al (2016) Distinct myeloid progenitor-differentiation pathways identified through single-cell RNA sequencing. Nat Immunol 17(6):666\u2013676","journal-title":"Nat Immunol"},{"key":"2_CR81","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/cr.2016.71","volume":"26","author":"M Zhao","year":"2016","unstructured":"Zhao M, Li L (2016) Dissecting the bone marrow hematopoietic stem cell niches. Cell Res 26:975","journal-title":"Cell Res"},{"issue":"4","key":"2_CR82","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.cell.2008.01.038","volume":"132","author":"SJ Morrison","year":"2008","unstructured":"Morrison SJ, Spradling AC (2008) Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 132(4):598\u2013611","journal-title":"Cell"},{"issue":"2","key":"2_CR83","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nri1779","volume":"6","author":"A Wilson","year":"2006","unstructured":"Wilson A, Trumpp A (2006) Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 6(2):93\u2013106","journal-title":"Nat Rev Immunol"},{"issue":"6960","key":"2_CR84","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/nature02040","volume":"425","author":"LM Calvi","year":"2003","unstructured":"Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC et al (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425(6960):841\u2013846","journal-title":"Nature"},{"issue":"11","key":"2_CR85","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/ncb2108","volume":"12","author":"H Kobayashi","year":"2010","unstructured":"Kobayashi H, Butler JM, O\u2019Donnell R, Kobayashi M, Ding BS, Bonner B et al (2010) Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nat Cell Biol 12(11):1046\u20131056","journal-title":"Nat Cell Biol"},{"issue":"3","key":"2_CR86","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.stem.2010.02.001","volume":"6","author":"JM Butler","year":"2010","unstructured":"Butler JM, Nolan DJ, Vertes EL, Varnum-Finney B, Kobayashi H, Hooper AT et al (2010) Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell 6(3):251\u2013264","journal-title":"Cell Stem Cell"},{"issue":"7571","key":"2_CR87","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature15250","volume":"526","author":"M Acar","year":"2015","unstructured":"Acar M, Kocherlakota KS, Murphy MM, Peyer JG, Oguro H, Inra CN et al (2015) Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal. Nature 526(7571):126\u2013130","journal-title":"Nature"},{"issue":"7308","key":"2_CR88","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nature09262","volume":"466","author":"S Mendez-Ferrer","year":"2010","unstructured":"Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA et al (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466(7308):829\u2013834","journal-title":"Nature"},{"issue":"5","key":"2_CR89","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.cell.2011.09.053","volume":"147","author":"S Yamazaki","year":"2011","unstructured":"Yamazaki S, Ema H, Karlsson G, Yamaguchi T, Miyoshi H, Shioda S et al (2011) Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche. Cell 147(5):1146\u20131158","journal-title":"Cell"},{"issue":"11","key":"2_CR90","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/nm.3706","volume":"20","author":"M Zhao","year":"2014","unstructured":"Zhao M, Perry JM, Marshall H, Venkatraman A, Qian P, He XC et al (2014) Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells. Nat Med 20(11):1321\u20131326","journal-title":"Nat Med"},{"issue":"7382","key":"2_CR91","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature10783","volume":"481","author":"L Ding","year":"2012","unstructured":"Ding L, Saunders TL, Enikolopov G, Morrison SJ (2012) Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481(7382):457\u2013462","journal-title":"Nature"},{"key":"2_CR92","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1146\/annurev-pathol-012615-044414","volume":"11","author":"J Hoggatt","year":"2016","unstructured":"Hoggatt J, Kfoury Y, Scadden DT (2016) Hematopoietic stem cell niche in health and disease. Annu Rev Pathol 11:555\u2013581","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"2_CR93","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.stem.2015.02.014","volume":"16","author":"K Schepers","year":"2015","unstructured":"Schepers K, Campbell TB, Passegue E (2015) Normal and leukemic stem cell niches: insights and therapeutic opportunities. Cell Stem Cell 16(3):254\u2013267","journal-title":"Cell Stem Cell"},{"issue":"7044","key":"2_CR94","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/nature03703","volume":"435","author":"DA Sipkins","year":"2005","unstructured":"Sipkins DA, Wei X, Wu JW, Runnels JM, Cote D, Means TK et al (2005) In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 435(7044):969\u2013973","journal-title":"Nature"},{"issue":"9","key":"2_CR95","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1182\/blood-2013-11-538694","volume":"123","author":"DS Krause","year":"2014","unstructured":"Krause DS, Lazarides K, Lewis JB, von Andrian UH, Van Etten RA (2014) Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche. Blood 123(9):1361\u20131371","journal-title":"Blood"},{"issue":"11","key":"2_CR96","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/nm.3364","volume":"19","author":"DS Krause","year":"2013","unstructured":"Krause DS, Fulzele K, Catic A, Sun CC, Dombkowski D, Hurley MP et al (2013) Differential regulation of myeloid leukemias by the bone marrow microenvironment. Nat Med 19(11):1513\u20131517","journal-title":"Nat Med"},{"issue":"7290","key":"2_CR97","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nature08851","volume":"464","author":"MH Raaijmakers","year":"2010","unstructured":"Raaijmakers MH, Mukherjee S, Guo S, Zhang S, Kobayashi T, Schoonmaker JA et al (2010) Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 464(7290):852\u2013857","journal-title":"Nature"},{"issue":"7487","key":"2_CR98","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nature12883","volume":"506","author":"A Kode","year":"2014","unstructured":"Kode A, Manavalan JS, Mosialou I, Bhagat G, Rathinam CV, Luo N et al (2014) Leukaemogenesis induced by an activating beta-catenin mutation in osteoblasts. Nature 506(7487):240\u2013244","journal-title":"Nature"},{"issue":"6","key":"2_CR99","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2014.02.014","volume":"14","author":"H Medyouf","year":"2014","unstructured":"Medyouf H, Mossner M, Jann JC, Nolte F, Raffel S, Herrmann C et al (2014) Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. Cell Stem Cell 14(6):824\u2013837","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2_CR100","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","volume":"21","author":"B Zhang","year":"2012","unstructured":"Zhang B, Ho YW, Huang Q, Maeda T, Lin A, Lee SU et al (2012) Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia. Cancer Cell 21(4):577\u2013592","journal-title":"Cancer Cell"},{"issue":"3","key":"2_CR101","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccr.2008.08.003","volume":"14","author":"C Dierks","year":"2008","unstructured":"Dierks C, Beigi R, Guo GR, Zirlik K, Stegert MR, Manley P et al (2008) Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 14(3):238\u2013249","journal-title":"Cancer Cell"},{"key":"2_CR102","doi-asserted-by":"publisher","first-page":"25476","DOI":"10.1038\/srep25476","volume":"6","author":"DA Irvine","year":"2016","unstructured":"Irvine DA, Zhang B, Kinstrie R, Tarafdar A, Morrison H, Campbell VL et al (2016) Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia. Sci Rep 6:25476","journal-title":"Sci Rep"},{"issue":"10","key":"2_CR103","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1182\/blood-2011-10-383752","volume":"119","author":"DA Irvine","year":"2012","unstructured":"Irvine DA, Copland M (2012) Targeting hedgehog in hematologic malignancy. Blood 119(10):2196\u20132204","journal-title":"Blood"},{"issue":"7569","key":"2_CR104","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature15248","volume":"525","author":"S Prost","year":"2015","unstructured":"Prost S, Relouzat F, Spentchian M, Ouzegdouh Y, Saliba J, Massonnet G et al (2015) Erosion of the chronic myeloid leukaemia stem cell pool by PPARgamma agonists. Nature 525(7569):380\u2013383","journal-title":"Nature"}],"container-title":["Advances in Experimental Medicine and Biology","Leukemia Stem Cells in Hematologic Malignancies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-7342-8_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T07:04:08Z","timestamp":1563865448000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-13-7342-8_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789811373411","9789811373428"],"references-count":104,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-7342-8_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"24 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}